Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NP272280A94

EI2BL Antibody (OTI9H7), Alexa Fluor™ 594, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP272280AF594

Catalog No. NP272280A94


Only null left
Add to Cart

Description

Description

EI2BL Monoclonal specifically detects EI2BL in Human, Mouse, Rat samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.
Specifications

Specifications

EI2BL
Monoclonal
Alexa Fluor 594
50 mM sodium borate with 0.05% sodium azide
MRI1
Full length recombinant protein of human EI2BL (NP_115661) produced in HEK293T cells.
Primary
Human, Mouse, Rat
IgG2b
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence
OTI9H7
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence
EC 5.3.1.23, M1Pi, Mediator of RhoA-dependent invasion, methylthioribose-1-phosphate isomerase, methylthioribose-1-phosphate isomerase homolog (S. cerevisiae), MGC3207, MRDI, MTNA, MTR-1-P isomerase, S-methyl-5-thioribose-1-phosphate isomerase, Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein, Ypr118w
Mouse
0.1 mL
84245
Store at 4°C in the dark.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.